Month: November 2019

Soligenix’s revenues for the quarter ended September 30, 2019 were $1.3 million as compared to $1.4 million for the quarter ended September 30, 2018. Revenues included payments on a contract in support of RiVax®, in addition to the grants received to support the development of SGX301 […]

NEW YORK, Nov. 11, 2019 (GLOBE NEWSWIRE) — XpresSpa Group Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), today announced that it will report its third quarter 2019 financial results after the close of the financial […]

Daniel P. Ring, Vice President of Business Development and Strategic Planning, will deliver a corporate presentation reviewing the Company’s two Phase 3 clinical programs and pipeline […]